These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1664925)

  • 21. Dopamine D2 receptors in the striatum and frontal cortex following chronic administration of haloperidol.
    Liskowsky DR; Potter LT
    Neuropharmacology; 1987 May; 26(5):481-3. PubMed ID: 2955242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ontogenetic expression of D2 dopamine receptor mRNA in rat corpus striatum.
    Chen JF; Weiss B
    Brain Res Dev Brain Res; 1991 Nov; 63(1-2):95-104. PubMed ID: 1665109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum.
    Laprade N; Soghomonian JJ
    Brain Res Mol Brain Res; 1995 Dec; 34(1):65-74. PubMed ID: 8750862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
    Humpel C; Knaus GA; Auer B; Knaus HG; Haring C; Theodorsson E; Saria A
    Synapse; 1990; 6(1):1-9. PubMed ID: 1697986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential modulation of dopamine D2 receptors by chronic haloperidol, nitrendipine, and pimozide.
    Tecott LH; Kwong LL; Uhr S; Peroutka SJ
    Biol Psychiatry; 1986 Oct; 21(12):1114-22. PubMed ID: 2428411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
    Calderon SF; Sanberg PR; Norman AB
    Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subchronic buspirone, mesulergine, and ICS 205-930 lack effects on D1 and D2 dopamine binding in the rat striatum during chronic haloperidol treatment.
    Young KA; Zavodny R; Hicks PB
    J Neural Transm Gen Sect; 1991; 86(3):223-8. PubMed ID: 1837997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine receptor gene expression by enkephalin neurons in rat forebrain.
    Le Moine C; Normand E; Guitteny AF; Fouque B; Teoule R; Bloch B
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):230-4. PubMed ID: 2296581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increase in striatal dopamine D2 receptor mRNA after lesions of haloperidol treatment.
    Coirini H; Schumacher M; Angulo JA; McEwen BS
    Eur J Pharmacol; 1990 Sep; 186(2-3):369-71. PubMed ID: 2127022
    [No Abstract]   [Full Text] [Related]  

  • 30. Blunting of the neurotensin mRNA response to haloperidol in the striatum of aging rats: possible relationship to decline in dopamine D2 receptor expression.
    Dobie DJ; Merchant KM; Hamblin MW; Vatassery GT; Dysken MW; Dorsa DM
    Brain Res; 1993 Jul; 616(1-2):105-13. PubMed ID: 8358601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D2 dopamine receptor gene expression in the rat striatum during ontogeny: an in situ hybridization study.
    Guennoun R; Bloch B
    Brain Res Dev Brain Res; 1991 May; 60(1):79-87. PubMed ID: 1680582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of ethanol and haloperidol on dopamine receptor (D2) density.
    Fuchs V; Coper H; Rommelspacher H
    Neuropharmacology; 1987 Aug; 26(8):1231-3. PubMed ID: 3658125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs.
    Miller JC
    J Neurochem; 1990 Apr; 54(4):1453-5. PubMed ID: 1690271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain.
    Angulo JA
    J Neurochem; 1992 Mar; 58(3):1104-9. PubMed ID: 1346626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of serotonergic agents on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum.
    Ishikane T; Kusumi I; Matsubara R; Matsubara S; Koyama T
    Eur J Pharmacol; 1997 Feb; 321(2):163-9. PubMed ID: 9063684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parallel decrease of glutamic acid decarboxylase and preproenkephalin mRNA in the rat striatum following chronic treatment with a dopaminergic D1 antagonist and D2 agonist.
    Caboche J; Vernier P; Julien JF; Rogard M; Mallet J; Besson MJ
    J Neurochem; 1991 Feb; 56(2):428-35. PubMed ID: 1824860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
    Korf J; Sebens JB
    J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reserpine-induced up-regulation of dopamine D2 receptors in the rat striatum is enhanced by denervation but not by chronic receptor blockade.
    Traub M; Reches A; Wagner HR; Fahn S
    Neurosci Lett; 1986 Oct; 70(2):245-9. PubMed ID: 2946007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of rat striatal D1 and D2 dopamine receptor mRNAs: ontogenetic and pharmacological studies.
    Creese I; Sibley DR; Xu SX
    Neurochem Int; 1992 Mar; 20 Suppl():45S-48S. PubMed ID: 1365454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adaptive changes in rat striatal preproenkephalin expression and dopamine-opioid interactions upon chronic haloperidol treatment during different developmental stages.
    De Vries TJ; Jonker AJ; Voorn P; Mulder AH; Schoffelmeer AN
    Brain Res Dev Brain Res; 1994 Apr; 78(2):175-81. PubMed ID: 7913003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.